期刊文献+

口服单剂量茶碱缓释片的人体生物等效性评价 被引量:4

Evaluation of Bioequivalence Assessment after Single Dose Theophylline Sustained-release Tablets in Healthy Volunteers
下载PDF
导出
摘要 目的研究两种国产茶碱缓释片在12名健康志愿者体内的药物动力学和相对生物利用度,并进行生物等效性评价。方法根据交叉试验方法口服单剂量200mg的两种茶碱缓释片,采用反相高效液相色谱法测定血清中茶碱的浓度。结果口服单剂量200mg试验品AUC,Cmax,Tmax,t1/2分别为(57.72±14.00)mg·h/L,(2.51±0.44)mg/L,(6.17±1.59)h,(19.44±5.94)h;对照品为(50.23±11.89)mg·h/L,(2.28±0.43)mg/L,(5.83±1.80)h,(16.52±5.28)h。结论两种国产茶碱缓释制剂的AUC0→36经双、单侧t检验,存在显著性差异,而Cmax,Tmax无显著性差异。 Objective:To study the pharmacokinetics and relative bioavailability of 2 domestic theophylline sustained-release tablets in 12 healthy volunteers,Methods:A single oral dose of 200 mg were given according to a crossover design,The theophylline concentrations in plasma were determined by RP-HPLC,Results:In the single dose of 200 mg experiment tablets the AUC,Cmax,Tmax and t1/2 of the subject were(57.72±14.00)mg·h/L,(2.51±0.44)mg/L,(6.17±1.59)h,(19.44±5.94)h;the standard tablets were (50.23±11.89)mg·h/L,(2.28±0.43)mg/L,(5.83±1.80)h,(16.52±5.28)h,Conclusion:The results of AUC0→36 showed significant difference between two kinds of sustained-release tablets,but Cmax and Tmax showed no significant difference,
出处 《中国药业》 CAS 2004年第6期30-31,共2页 China Pharmaceuticals
关键词 茶碱 反相高效液相色谱 生物利用度 生物等效性 Theophylline RP-HPLC Bioavailability Bioequivalence
  • 相关文献

参考文献4

共引文献36

同被引文献18

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部